See analyst estimates and all valuation multiples for Medical Supplies
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$213B | 4.9x | 19.6x | |
$165B | 6.8x | 21.6x | |
$74.7B | 3.5x | 11.8x | |
$43.5B | 1.7x | 10.2x | |
$41.6B | 7.0x | 19.6x | |
$37.3B | 7.0x | 19.1x | |
$27.2B | 3.8x | 15.7x | |
$26.0B | 4.6x | 15.9x | |
$24.9B | 1.1x | 6.1x | |
$18.6B | 5.8x | 18.8x | |
$18.5B | 3.0x | 11.9x | |
$17.5B | 5.9x | 23.7x | |
$12.6B | 1.9x | 11.0x | |
$10.1B | 2.8x | 12.6x | |
$7.9B | 2.6x | 11.7x | |
$6.5B | 5.0x | 20.4x | |
$6.5B | 5.7x | 11.4x | |
$4.9B | 1.3x | 7.2x | |
$4.1B | 1.5x | 7.9x | |
$4.1B | 3.5x | 12.8x | |
$3.8B | n/a | n/a | |
$3.6B | 1.7x | 10.2x | |
$3.5B | 2.6x | 8.4x | |
$3.0B | 1.5x | 6.9x | |
$2.2B | n/a | n/a | |
$2.1B | 10.4x | 38.5x | |
$2.1B | 1.9x | 5.2x | |
$1.8B | 9.4x | n/a | |
$1.7B | n/a | n/a | |
$1.4B | 2.2x | 8.4x | |
$1.3B | 0.9x | 8.4x | |
$1.1B | n/a | n/a | |
$1.1B | 11.7x | 52.6x | |
$1.1B | n/a | n/a | |
$980M | 0.8x | 4.6x | |
$689M | 1.1x | 5.1x | |
$666M | 0.3x | 5.5x | |
$631M | 9.4x | -7.8x | |
$535M | 4.5x | 48.2x | |
$527M | 3.7x | 8.6x | |
$410M | n/a | n/a | |
$347M | n/a | n/a | |
$295M | n/a | n/a | |
$259M | 1.2x | 34.0x | |
$247M | 0.9x | 6.9x | |
$244M | n/a | n/a | |
$214M | n/a | n/a | |
$207M | 6.9x | 36.0x | |
$206M | 1.2x | 5.4x | |
$198M | 3.2x | 16.5x | |
$195M | 0.8x | n/a | |
$188M | 5.0x | -110.5x | |
$171M | 0.7x | 3.1x | |
$142M | n/a | n/a | |
$108M | 57.2x | n/a | |
$84.9M | 1.3x | 9.5x | |
$80.9M | n/a | n/a | |
$58.9M | n/a | n/a | |
$49.5M | 0.9x | 11.1x | |
$44.8M | n/a | n/a | |
$41.3M | 6.3x | n/a | |
$30.5M | 0.4x | 26.4x | |
$25.6M | n/a | n/a | |
$18.2M | n/a | n/a | |
$16.7M | n/a | n/a | |
$15.3M | n/a | n/a | |
$14.5M | n/a | n/a | |
$11.7M | 13.9x | -7.4x | |
$10.2M | n/a | n/a | |
$7.0M | n/a | n/a | |
$1.2M | n/a | n/a | |
$1.1M | n/a | n/a | |
$0.6M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Medical Supplies